Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Transgene announces encouraging results from phase I oncology trials

Feb. 12, 2003

Clinical toxicity and pharmacokinetics determined for lead alkycycline

Feb. 11, 2003

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

Metvix launched in Germany

Feb. 11, 2003

Antitumor protein tyrosine kinase inhibitors newly identified at Pfizer

Feb. 11, 2003

NeoPharm to resume LEP clinical trials

Feb. 11, 2003

LY-355703 associated with peripheral neuropathy and myalgia in early clinical studies

Feb. 10, 2003

Access program launched for cetuximab

Feb. 10, 2003

AstraZeneca files European MAA for Faslodex in advanced breast cancer

Feb. 10, 2003

Novel protein kinase inhibitors in early development at Aventis

Feb. 10, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...